Skip to main content
Novo Nordisk A/S (CPH: NOVO.B)
Denmark flag Denmark · Delayed Price · Currency is DKK
589.20
-154.00 (-20.72%)
Dec 20, 2024, 4:59 PM CET

Novo Nordisk Revenue

Novo Nordisk had revenue of 71.31B DKK in the quarter ending September 30, 2024, with 21.42% growth. This brings the company's revenue in the last twelve months to 270.58B, up 26.15% year-over-year. In the year 2023, Novo Nordisk had annual revenue of 232.26B with 31.26% growth.

Revenue (ttm)
270.58B
Revenue Growth
+26.15%
P/S Ratio
9.71
Revenue / Employee
3.76M
Employees
64,319
Market Cap
2,606.81B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023232.26B55.31B31.26%
Dec 31, 2022176.95B36.15B25.68%
Dec 31, 2021140.80B13.85B10.91%
Dec 31, 2020126.95B4.93B4.04%
Dec 31, 2019122.02B10.19B9.11%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Coloplast A/S 27.03B
Genmab A/S 19.84B
Demant A/S 22.84B
Zealand Pharma A/S 76.87M
H. Lundbeck A/S 21.44B
H. Lundbeck A/S 21.44B
ALK-Abelló A/S 5.38B
Ambu A/S 5.39B
Revenue Rankings

Novo Nordisk News

More News